Retatrutide is a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating these receptors, https://aronwoax086360.weblogco.com/36380209/tirzepatide-a-promising-new-treatment-for-obesity